Where does Corcept Therapeutics Incorporated rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Corcept Therapeutics Incorporated ranks #3,592 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Corcept Therapeutics Incorporated hold?

Corcept Therapeutics Incorporated holds 102 US utility patents granted between 2016 and 2025, spanning 17 technology areas.

What is Corcept Therapeutics Incorporated's Innovation Score?

Corcept Therapeutics Incorporated has an Innovation Score of 49.5 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Corcept Therapeutics Incorporated's patent grant rate increasing or decreasing?

Corcept Therapeutics Incorporated's recent grant velocity is +148% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Corcept Therapeutics Incorporated's patents?

Corcept Therapeutics Incorporated's patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Corcept Therapeutics Incorporated patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Corcept Therapeutics Incorporated

Q: What technology areas does Corcept Therapeutics Incorporated focus on?

Corcept Therapeutics Incorporated's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 80 patents. Grants appear in 17 CPC subclasses total.

USPTO PatentsView assignee record - 102 granted patents across 17 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Corcept ranks #3,592 of 49,997 tracked US assignees by granted-patent volume, with 102 patents across 17 technology areas.

#3,592
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.5/100): 18.4
avg claims per patent: +148%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3592 · US Corporation #3,592 · 102 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 102 grants
TOP-DECILE #3,592/49,997
PHOTO-FINISH Aveva Software
CPC-FOCUS A61K · 17 areas
INNOV-PAR 49.5/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +148% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aveva Software, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Corcept Therapeutics… · this assignee

50
Daido Steel · near

50
Hyosung Heavy… · near

50
National University… · near

50
Zhejiang Sunny Optical · near

50
3D Lighting… · lowest

7

What this shows Corcept's Innovation Score is 49.5/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Corcept's grants concentrate

Corcept Therapeutics Incorporated is a focused PatentsView assignee: 17 CPC subclasses with 78.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (19 grants) versus a trough of 2 in 2016. By volume, Corcept sits between Aveva Software, LLC and H.C. Starck Inc..

Corcept's three-year grant acceleration

From 2019–2021 to 2022–2024, Corcept Therapeutics Incorporated moved from 37 to 44 grants (1.19x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #800. See the growth leaderboard.

Aveva Software

102
Bostik

102
Central South Uni…

102
Colder Products

102
Dupont Nutrition…

102
G D Societa' PER…

102
Genesis Photonics

102
H C Starck

102
Corcept Therapeut… ◀

102

What this shows Corcept holds 102 patents at rank #3,592, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Corcept

By rank, the assignees closest to #3,592 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Corcept's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Corcept, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Daido Steel Co., Ltd. 50 Hyosung Heavy Industries Corporation 50 Zhejiang Sunny Optical Co., Ltd 50 National University Corporation Ehime University 50

Similar claim depth

Nearest assignees by average claims per patent (18.4 here).

Really Right Stuff, LLC 18.4 avg First Orion Corp. 18.4 avg Transform SR Brands LLC 18.4 avg T.J.Smith and Nephew, Limited 18.4 avg

Corcept's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Corcept Therapeutics Incorporated patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	2.0%
2017	2	2.0%
2018	9	8.8%
2019	14	13.7%
2020	10	9.8%
2021	13	12.7%
2022	9	8.8%
2023	16	15.7%
2024	19	18.6%
2025partial year	8	7.8%

Which technologies does Corcept Therapeutics Incorporated patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 80

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 71

C07D - Heterocyclic Compounds 29

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

A61B - DIAGNOSIS; SURGERY; Identification 9

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

C12Y - Enzymes 2

G06V - Image OR Video Recognition OR Understanding 2

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 2

G06T - Image Data Processing OR Generation, IN General 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

C07K - Peptides 2

Top 15 of 17 technology areas

Where it ranks

Overall rank by patents

#3,592

of 49,997 tracked assignees

Innovation Score

49.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Corcept Therapeutics Incorporated's patent record in context - here's where to go next.

Corcept Therapeutics Incorporated's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 78.4% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #3,592 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Corcept Therapeutics Incorporated against Aveva Software, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.